Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Inventory (2018 - 2025)

Historic Inventory for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $149.1 million.

  • AdaptHealth's Inventory rose 1168.78% to $149.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $149.1 million, marking a year-over-year increase of 1168.78%. This contributed to the annual value of $139.8 million for FY2024, which is 2305.49% up from last year.
  • As of Q3 2025, AdaptHealth's Inventory stood at $149.1 million, which was up 1168.78% from $148.9 million recorded in Q2 2025.
  • AdaptHealth's Inventory's 5-year high stood at $149.1 million during Q3 2025, with a 5-year trough of $75.5 million in Q1 2021.
  • Moreover, its 5-year median value for Inventory was $123.1 million (2021), whereas its average is $118.4 million.
  • Per our database at Business Quant, AdaptHealth's Inventory surged by 32012.03% in 2021 and then plummeted by 2016.87% in 2024.
  • AdaptHealth's Inventory (Quarter) stood at $123.1 million in 2021, then grew by 3.78% to $127.8 million in 2022, then dropped by 11.05% to $113.6 million in 2023, then rose by 23.05% to $139.8 million in 2024, then increased by 6.61% to $149.1 million in 2025.
  • Its Inventory stands at $149.1 million for Q3 2025, versus $148.9 million for Q2 2025 and $129.3 million for Q1 2025.